Brain Tumor Trials Collaborative   Report issue

Academic/Hospital Phase 2
Founded: United States (2003)

Organization Overview

First Clinical Trial
2011
NCT01266031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

bevacizumab (avastin) (2 trials)

cilengitide (1 trial)

vorinostat (zolinza) (1 trial)

Drugs in Other Trials (1)

lacosamide (vimpat) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glioblastoma (Phase 2)

Glioma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4